1 completed, 1 recruiting. 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow Secukinumab 150mg s.c.: new trials by email Literature Review of Secukinumab 150mg s.c. trials Research Report on Secukinumab 150mg s.c.
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetic, Safety and Immunogenicity Study of New Process CMAB015 and Cosentyx in Healthy Volunteers Secukinumab 150mg s.c. - Psoriasis | Phase 1 | Completed | Taizhou Mabtech Pharmaceutical Co.,Ltd | 114 | 2025-12-15 | 2026-10-21 |
| A Study Evaluating the Efficacy of Secukinumab 300mg in Chinese Adults With Active Ankylosing Spondylitis Secukinumab 300mg s.c., Secukinumab 150mg s.c. - Ankylosing Spondylitis (AS) | Phase 4 | Recruiting | Tongji Hospital | 100 | 2024-06-14 | 2026-01-27 |
Psoriasis (1) · Spondylitis, Ankylosing (1)
Taizhou Mabtech Pharmaceutical Co.,Ltd (1) · Tongji Hospital (1)
China (2)